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Abstract: Mesenchymal stem cells (MSCs) have the capacity to self‐renew and differentiate into specific
cell types and are, therefore, key players during tissue repair and regeneration. The use of MSCs for
the regeneration of tissues in vivo is increasingly being explored and already constitutes a promising
alternative to existing clinical treatments. MSCs also exert paracrine and trophic functions, including the
promotion of innervation that plays fundamental roles in regeneration and in restoration of the function
of organs. Human bone marrow stem cells (hBMSCs) and human dental pulp stem cells (hDPSCs)
have been used in studies that aimed at the repair and/or regeneration of bone or other tissues of the
craniofacial complex. However, the capabilities of hBMSCs and hDPSCs to elicit the growth of specific
axons in order to reestablish functional innervation of the healing tissues are not known. Here, we
compared the neurotrophic effects of hDPSCs and hBMSCs on trigeminal and dorsal root ganglia neurons
using microfluidic organs‐on‐chips devices. We found that hDPSCs express significantly higher levels of
neurotrophins than hBMSCs and consequently neurons cocultured with hDPSCs develop longer axons
in the microfluidic co‐culture system when compared to neurons cocultured with hBMSCs. Moreover,
hDPSCs elicited the formation of extensive axonal networks and established close contacts with neurons,
a phenomenon not observed in presence of hBMSCs. Taken together, these findings indicate that hDPSCs
constitute a superior option for restoring the functionality of damaged craniofacial tissues, as they are
able to support and promote extensive trigeminal innervation.
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LIST OF NONSTANDARD ABBREVIATIONS 30 
BDNF    Brain-Derived Neurotrophic Factor 31 
CGRP    Calcitonin Gene Related Peptide 32 
DMEM/F12   Dulbecco's Modified Eagle Medium: Nutrient Mixture F-12 33 
DRG    Dorsal Root Ganglia 34 
FBS    Fetal Bovine Serum 35 
GDNF    Glial-cell Derived Neurotrophic Factor  36 
hBMSC   Human Bone Marrow Stem Cell 37 
hDPSC   Human Dental Pulp Stem Cell 38 
MSC    Mesenchymal Stem Cell 39 
PBS    Phosphate Buffer Saline 40 
PCR    Polymerase Chain Reaction 41 
PDMS    Polydimethylsiloxane  42 
NGF    Nerve Growth Factor 43 
NT-3    Neurotrophin-3 44 
TGG    Trigeminal Ganglia 45 
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ABSTRACT 47 
Mesenchymal stem cells (MSCs) have the capacity to self-renew and differentiate into specific cell 48 
types and are therefore key players during tissue repair and regeneration. The use of MSCs for the 49 
regeneration of tissues in vivo is increasingly being explored and already constitutes a promising 50 
alternative to existing clinical treatments. MSCs also exert paracrine and trophic functions, 51 
including the promotion of innervation that plays fundamental roles in regeneration and in 52 
restoration of the function of organs. Human bone marrow stem cells (hBMSCs) and human dental 53 
pulp stem cells (hDPSCs) have been used in studies aimed at the repair and/or regeneration of bone 54 
or other tissues of the craniofacial complex. However, the capabilities of hBMSCs and hDPSCs to 55 
elicit the growth of specific axons in order to re-establish functional innervation of the healing 56 
tissues are not known. Here we compared the neurotrophic effects of hDPSCs and hBMSCs on 57 
trigeminal and dorsal root ganglia neurons using microfluidic organs-on-chips devices. We found 58 
that hDPSCs express significantly higher levels of neurotrophins than hBMSCs and consequently 59 
neurons co-cultured with hDPSCs develop longer axons in the microfluidic co-culture system when 60 
compared to neurons co-cultured with hBMSCs. Moreover, hDPSCs elicited the formation of 61 
extensive axonal networks and established close contacts with neurons, a phenomenon not observed 62 
in presence of hBMSCs. Taken together these findings indicate that hDPSCs constitute a superior 63 
option for restoring the functionality of damaged craniofacial tissues, as they are able to support and 64 
promote extensive trigeminal innervation. 65 
 66 
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INTRODUCTION 68 
Mesenchymal stem cells (MSCs) have attracted significant attention in last decades because of 69 
their potential use in regenerative medicine. MSCs are characterized by the ability to differentiate 70 
along the osteogenic, chondrogenic and adipogenic lineages, and can thus be exploited in 71 
therapeutic regimens aimed at the regeneration of different tissues such as bone and cartilage. Apart 72 
from their differentiation potential, MSCs have been shown to exert paracrine and trophic effects, 73 
including immunomodulation, augmentation of angiogenesis and neurogenesis, and promotion of 74 
cell survival [1].  75 
MSCs have been isolated from many organs, and although all these different cell populations 76 
display similar differentiation potential, they vary in their trophic properties [2–5]. Human bone 77 
marrow stem cells (hBMSCs) represent the golden standard for bone repair, and have been used in 78 
studies aiming to regenerate various osseous structures, including craniofacial bones [6]. Dental 79 
MSCs were initially isolated from the pulp of human third molars [7] and since then dental MSCs 80 
have also been isolated from other locations, such as the pulp of exfoliated deciduous teeth, the 81 
apical papilla, the dental follicle, and the periodontal ligament [8]. These dental-derived MSCs 82 
populations vary in their expression of stem cell surface markers and in their ability to differentiate 83 
into distinctive cell lineages [9].  84 
Human dental pulp stem cells (hDPSCs) have been extensively studied and in a dental clinical 85 
setting constitute very attractive candidates for cell-based regenerative therapies [10–12].  In vitro 86 
hDPSCs display a pattern of protein expression similar to hBMSCs [5]. However compared to 87 
hBMSCs, hDPSCs exhibit higher clonogenic and proliferative potentials, and they maintain a high 88 
rate of proliferation even after extensive sub-culturing [5]. hDPSCs originate from craniofacial 89 
embryonic tissues that do not express the Hox genes and therefore are not affected by the Hox-code 90 
as are other body tissues from where hBMSCs are derived [13]. Hox-genes are expressed in a 91 
spatially distinct pattern along the body axis where they provide cells with positional information 92 
[14, 15]. The absence of Hox genes in DPSCs confers them with a peculiar plasticity, as 93 
demonstrated by their ability to fully embrace the Hox-code of the site of engraftment upon 94 
transplantation in ectopic compartments [16]. In contrast, BMSCs transplanted into the craniofacial 95 
complex maintain the Hox-code of the tissue of origin, which hinders their differentiation [16].  96 
Therefore, DPSCs are deemed preferable candidates for the regeneration of teeth and other 97 
craniofacial tissues [11, 17, 18]. 98 
A key component for successful repair processes is the efficient re-establishment of the 99 
appropriate neuronal network within the regenerating tissue. Indeed, innervation plays fundamental 100 
roles in the formation, homeostasis, and function of most tissues and organs [19]. Different classes 101 
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of nerve fibers exert distinctive functions in the various organs [19–21]. Sensory neurons projecting 102 
from the trigeminal ganglion provide sensation to most craniofacial tissues and organs [22]. In 103 
teeth, myelinated and non-myelinated trigeminal neurons convey sensory information [19, 23]. 104 
Craniofacial pathologies, traumas and interventions are commonly associated with impairment or 105 
loss of trigeminal innervation, which can result in long term neurosensory and functional 106 
disturbances [22, 24]. In severe cases, nerves resected from other parts of the body are grafted to 107 
achieve trigeminal nerve repair, but this is a highly invasive procedure with suboptimal outcomes 108 
[25]. Recent scientific evidence supports the notion that nerve-derived signals also play an 109 
important role in the repair of orofacial tissues. For example, in salivary glands, parasympathetic 110 
neurons secrete signals that are necessary for the activation of stem/progenitor cells during 111 
regenerative processes [26, 27]. It is becoming clear that in stem cell-based therapies it is essential 112 
to promote accurate re-innervation of regenerating tissues and elicit the growth of axons from 113 
specific neuronal subtypes. Therapies aiming at craniofacial regeneration thus need to re-establish 114 
proper trigeminal innervation to ensure an effective tissue repair and functionality.  115 
The study of cell-cell interactions is increasingly supported by state-of-the-art culture and co-116 
culture systems. Among these, organs-on-chips represent the most promising tools to emulate and 117 
study in vivo complex microenvironments. Organs-on-chips are devices with separate 118 
compartments lined by living cells and provide effective in vitro tools for recapitulating and 119 
mimicking multicellular architecture, cell-cell interactions, and physical microenvironment of 120 
functional units of living organs [28]. These models allow precise control of the secreted signaling 121 
molecules and provide a real time readout on basal cell functions that permits the reconstitution of 122 
organ physiology.  123 
Here we investigated the neurotrophic effects of hDPSCs and hBMSCs on trigeminal and 124 
dorsal root ganglia using a microfluidic organ-on-chip system. The results showed that, compared 125 
to hBMSCs, hDPSCs express higher levels of neurotrophins, promote longer axon growth and 126 
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MATERIALS AND METHODS 132 
Collection of human cells 133 
The procedure for anonymized human dental pulp stem cells (hDPSCs) collection at the 134 
Zentrum für Zahnmedizin, Zürich, was approved by the Kantonale Ethikkommission of Zurich 135 
(reference number 2012-0588) and the patients gave their written informed consent. All procedures 136 
were performed in accordance with the current guidelines. Tooth extractions were performed by 137 
professional dentists. Human bone marrow stromal/stem cells (hBMSCs) were kindly provided by 138 
Prof. Ivan Martin (University Hospital Basel, Basel, Switzerland) and Prof. Franz Weber 139 
(University of Zurich, Zurich, Switzerland; cells from ATCC).  140 
Cell culture and expansion 141 
hDPSCs were expanded as monolayers on T-150 culture flasks (Sarsted AG, Switzerland)  in  142 
Dulbecco's Modified Eagle Medium: Nutrient Mixture F-12 (DMEM/F12; ThermoFisher / Life 143 
Technologies, Switzerland) supplemented with 10% Fetal Bovine Serum (FBS, Bioswisstech AG, 144 
Switzerland), 100 U/ml penicillin/streptomycin (Sigma-Aldrich/Merck, Darmstadt, Germany), and 145 
Amphotericin B 0.25 μg/μL (ThermoFisher Scientific, Switzerland)  incubated at 37°C in 5% CO2. 146 
hBMSCs were expanded in MesenPro medium (Cat. n°: 12746012, ThermoFisher). The medium 147 
was replaced every second day. Cells were passaged once a confluence of 70-80% was reached. 148 
Cells were washed once with phosphate buffered saline (PBS) before trypsin was added for 3 min at 149 
37°C for their detachment. Trypsin was blocked by addition of 5 volumes of DMEM/F12 150 
supplemented with 10% FBS.  151 
Gene expression analysis - Real time PCR 152 
Cells were collected by trypsinization, snap-frozen in liquid nitrogen and stored at -80°C. 153 
Trigeminal ganglia (TGG) and dorsal root ganglia (DRG) were dissected, immediately snap-frozen 154 
in liquid nitrogen and stored at -80°C. 155 
RNA isolation and purification. RNA isolation on snap-frozen cells and TGG/DRG was 156 
performed with the RNeasy Plus Universal Mini Kit according to the instructions (Qiagen AG, 157 
Hombrechtikon ZH, Switzerland).  158 
cDNA synthesis. Reverse transcription of the isolated RNA was performed using the iScript™ 159 
cDNA synthesis Kit and according to the instructions given (Bio-Rad Laboratories AG, Cressier 160 
FR, Switzerland). Briefly, 1000 ng of RNA were used for reverse transcription into cDNA. 161 
Nuclease-free water was added to add up to a total of 15 μl. 4 μl of 5x iScript reaction mix and 1 μl 162 
of iScript reverse transcriptase were added per sample in order to obtain a total volume of 20 μl. 163 
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The reaction mix was then incubated for 5 min at 25°C, for 30 min at 42°C and for 5 min at 85°C 164 
using a Biometra TPersonal Thermocycler (Biometra AG, Göttingen, Germany). 165 
Quantitative real-time PCR. The 3-step quantitative real-time PCRs were performed using an 166 
Eco Real-Time PCR System (Illumina Inc., San Diego CA, USA). Expression level analysis of 167 
hGAPDH, m36B4 (housekeeping gene), hNGF, hBDNF, hGDNF, hNT-3, mNtrk1, mNtrk2, mNtrk3, 168 
mNGFR were carried out using the SYBR® Green PCR Master Mix (Applied Biosystems, Carlsbad 169 
CA, USA) in combination with specific oligonucleotide primers: hNGF, Fw: 5’- GGC AGA CCC 170 
GCA ACA TTA CT-3’, Rv: 5’- CAC CAC CGA CCT CGA AGT C-3’; hBDNF, Fw: 5’- GGC 171 
TTG ACA TCA TTG GCT GAC-3’, Rv: 5’- CAT TGG GCC GAA CTT TCT GGT-3’; hGDNF, 172 
Fw: 5’- AGC AGT GAC TCA AAT ATG CCA GA-3’, Rv: 5’- GCC TCT CCG ACC TTT TCC 173 
TC-3’; hNT-3, Fw, 5’- AAC GCG ATG TAA GGA AGC CA-3’, Rv: 5’- AGT GCT CGG ACG 174 
TAG GTT TG-3’; hGAPDH, Fw: 5’- AGG GCT GCT TTT AAC TCT GGT-3’, Rv: 5’- CCC CAC 175 
TTG ATT TTG GAG GGA-3; mNtrk1, Fw: 5’-AGT TAC CTG GAC GTT CTG GG-3’, Rv: 5’- 176 
TGC TGA GGG TGA GAG ACT TG-3’; mNtrk2, Fw: 5’- TGT GGC TCA AGA CTC TCC AG-177 
3’, Rv: 5’- AGA CTT TCC TTC CTC CAC GG-3’; mNtrk3, Fw: 5’- CTT TGA GTC TGA TGC 178 
GAG CC-3’, Rv: 5’- TGG TGT AGT GAT GCC ATG GT-3’; mNGFR, Fw: 5’- CTG CCT TCC 179 
TCT GTC TGT CA-3’, Rv: 5’- TTG GAT TAT GGG GTG GGT CC-3’. 180 
The reaction mix was composed of 5 μl of SYBR® Green PCR Master Mix reverse and 181 
forward primers (200 nM), and 2 ng of template cDNA. The thermocycling conditions were: 95°C 182 
for 10 min, followed by 40 cycles of 95°C for 15 sec, 55°C for 30 sec and 60°C for 1 min. Melt 183 
curve analysis was performed at 95°C for 15 sec, 55°C for 15 sec and 95°C for 15 sec. Expression 184 
levels were calculated by the comparative ΔCt method (2−ΔCt formula), normalizing to the Ct-185 
value of the GAPDH housekeeping gene. Gene expression analysis was performed on hDPSCs and 186 
hBMSCs isolated from 12 patients (hDPSCs and hBMSCs were derived from different patients). 187 
 188 
ELISA assay 189 
 hDPSCs and hBMSCs were seeded in equal amounts in 10cm Petri dishes. Cells were 190 
cultured in Dulbecco's Modified Eagle Medium: Nutrient Mixture F-12 (DMEM/F12; 191 
ThermoFisher / Life Technologies, Switzerland) supplemented with 10% Fetal Bovine Serum (FBS, 192 
Bioswisstech AG, Switzerland), 100 U/ml penicillin/streptomycin (Sigma-Aldrich/Merck, 193 
Darmstadt, Germany) for 48 hours. The culture medium was collected and centrifuged at 1500 rpm 194 
for 10 minutes. The supernatant was further filtered with a 0.22 m filter. Culture media were then 195 
analysed with ELISA kits against human NGF (EHNGF,  ThermoFisher Scientific, Zurich, 196 
Switzerland), human BDNF (ab99978, Abcam, Cambridge, UK), human GDNF (EHGDNF, 197 
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ThermoFisher Scientific, Zurich, Switzerland), human Neutrophin-3 (NT3) (EHNT3, ThermoFisher 198 
Scientific, Zurich, Switzerland). 199 
 200 
Western blot 201 
Total protein extracts were prepared according to standard protocols from snap-frozen TGGs 202 
and DRGs. Proteins were subjected to SDS–polyacrylamide gel electrophoresis (SDS-PAGE) 203 
separation and blotting. The following antibodies were used: rabbit pAb anti-TrkA (1:100, Sigma-204 
Aldrich, 06-574), rabbit pAb anti-TrkB (1:100, R&D Systems, AF1494), rabbit pAb anti-TrkC 205 
(1:100, R&D Systems, AF1404), rabbit mAb anti-nerve growth factor receptor (NGFR/p75) (1:100, 206 
Sigma-Aldrich, N3908). Antibody binding was detected by using an appropriate horseradish 207 
peroxidase–conjugated IgG and revealed by ECL (Lumi-Light Western Blotting Substrate, 208 
12015200001, Merck, Darmstadt, Germany). 209 
Preparation of microfluidic devices 210 
Microfluidic devices were prepared as previously described [29, 30]. Glass coverslips were 211 
coated overnight at 37 °C with 0.1 mg/ml poly-D-lysine and stored in 70% ethanol at 4°C. 212 
Polydimethylsiloxane (PDMS) microfluidic devices (Millipore A150, Switzerland, 2x2cm) were 213 
punched with a 1mm - diameter biopsy punch on the neuronal side to enable the insertion of the 214 
trigeminal ganglion and then sterilized with 70% ethanol. Both glass coverslips and microfluidic 215 
devices were then let dry completely under the laminar flow hood for approx. 2 hours. In sterile 216 
conditions, glass coverslips were placed in a 6-wells plate. The microfluidic devices were then 217 
mounted onto the glass coverslips and pressed gently to ensure proper adhesion. After mounting, 218 
the microfluidic devices were coated with laminin (5μg/ml, in Neurobasal medium) overnight at 37 219 
°C. In order to prevent the persistence of air bubbles in the culture chambers, the coated 220 
microfluidic devices were placed under vacuum. After coating, the laminin solution was removed, 221 
and the culture chambers filled with the appropriate culture medium. 222 
Mouse handling and trigeminal and dorsal root ganglia dissection 223 
All mice were maintained and handled according to the Swiss Animal Welfare Law and in 224 
compliance with the regulations of the Cantonal Veterinary Office, Zurich (License number: 225 
151/2014). C57/BL6J mice were time-mated. Successful mating was assessed by vaginal plug 226 
check, and day of plug was considered as day of embryonic development 0.5 (E0.5). Trigeminal 227 
ganglia and dorsal root ganglia were dissected from embryonic day 14.5-16.5 (E14.5-E16.5) mouse 228 
embryos. Dissections were performed in cold Dulbecco’s phosphate buffered saline (PBS). 229 
Dissected ganglia were preserved in PBS, on ice, until culture. 230 
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Trigeminal ganglia and dorsal root ganglia were then cultured in Neurobasal medium (Gibco) 231 
supplemented with B27 (Gibco 17504-044), GlutaMAX, penicillin/streptomycin (10U/ml), 50 232 
ng/ml nerve growth factor (NGF, R&D Systems) and 0.25 pM Arabinose Cytoside.  233 
Co-culture of trigeminal and dorsal root ganglia and hMSCs 234 
Trigeminal ganglia and dorsal root ganglia were placed through the punched hole into the 235 
neuronal chamber of the microfluidic device [29]. Ganglia were cultured alone for 5-7 days, until 236 
axons were projected into the stem cells chamber. Cells were then added to the co-culture system. 237 
20 μl of hDPSCs or hBMSCs were added directly in the stem cell chambers at a density of 1*104 238 
cells/chamber. Cells were let attach for 1 hour and 30 minutes; then 300 μl of the appropriate 239 
medium were added to all chambers. Co-cultures were maintained for four days. At the end of the 240 
culture period, medium was removed, and all chambers were washed once with 300 μl PBS for 10 241 
minutes. Afterwards, the samples were fixed in paraformaldehyde 4% (PFA 4%), 300 μl/ chamber, 242 
for 15 minutes. Chambers were then washed again with 300 μl PBS/chamber for 10 minutes and 243 
were stored at 4°C in PBS. 244 
Immunofluorescent staining 245 
Fixed samples were permeabilised by incubating them in 1% Triton/PBS for ten minutes. Non-246 
specific sites were blocked with PBS, 0.1% Triton and 1% bovine serum albumin (BSA) for 30 247 
minutes at RT, 90-100μl per chamber. Trigeminal ganglia, dorsal root ganglia and co-cultures were 248 
incubated overnight with the following primary antibodies (1° AB): mouse IgG1 α-neurofilament 249 
(α-NF) antibody (1:100, Hybridoma Bank, Iowa City, USA), rabbit mAb anti-neurofilament (1:200, 250 
Cell Signaling Technology, 2837), rabbit pAb anti-Peripherin (1:200, Abcam, ab4666), mouse mAb 251 
anti-Vimentin (1:100, DAKO, M0725), rabbit mAb anti-TrkA (1:50, Abcam, ab76291), rabbit pAb 252 
anti-TrkA (1:100, Sigma-Aldrich, 06-574), rabbit pAb anti-TrkB (1:100, R&D Systems, AF1494), 253 
rabbit pAb anti-TrkC (1:100, R&D Systems, AF1404), rabbit mAb anti-nerve growth factor 254 
receptor (NGFR/p75) (1:100, Sigma-Aldrich, N3908), mouse mAb anti- Calcitonin Gene Related 255 
Peptide (CGRP) (1:200, Abcam, ab81887), rabbit pAb anti--III-tubulin (1:200, Abcam, ab18207), 256 
rabbit pAb anti-Synapsin I (1:100, Abcam, ab64581), rabbit pAb anti-human-Nuclear Mitotic 257 
Antigen (NuMA, 1:100, GeneTex, GTX113510) diluted in PBS supplemented with 1% bovine 258 
serum albumin (BSA). The samples were washed three times (5 minutes each) with PBS + 0.5% 259 
Tween. The co-cultures were then incubated overnight with the following secondary antibodies (50-260 
60μl per chamber): Alexa-Fluor488 conjugated anti-Rabbit (A-11034, ThermoFisher), Alexa-261 
fluor568 conjugated anti-mouse (A-11004, ThermoFisher) diluted 1:250 in 1% BSA/PBS. Co-262 
cultures were then washed three times (5 minutes each) with PBS and successively incubated with 263 
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4',6-diamidino-2-phenylindole (DAPI) for ten minutes at RT. Samples were finally washed twice (5 264 
minutes each) with PBS. Microfluidic devices were then removed from the 6-wells plates and 265 
mounted on slides. TGG and DRG were cleared with Focus Clear (CelExplorer) overnight at 4°C. 266 
Co-cultures were imaged with a Leica DM6000 microscope equipped with a Leica DFC350FX 267 
camera and the Leica Application Suite Advanced Fluorescence (LAS AF) software. TGGs and 268 
DRGs were imaged with a Leica SP8 Confocal Laser Scanning Microscope (CLSM). Tile scans 269 
were stitched using the Mosaic J plugin of Fiji/Imagej [31] and manually aligned when needed. 270 
The same protocol was applied for the immunofluorescent imaging of neurotrophins in 271 
hDPSCs and hBMSCs. The following primary antibodies were used: Goat pAb anti-human -nerve 272 
growth factor (NGF) (1:100, R&D Systems, AF-256-NA), mouse mAb anti-brain derived 273 
neurotrophic factor (BDNF) (1:100, R&D Systems, MAB248-100), rabbit pAb anti-glia derived 274 
neurotrophic factor (GDNF) (1:100, Abcam, ab18956), rabbit pAb anti-neutrophin 3 (NT-3) (1:100, 275 
Abcam, ab65804). The following secondary antibodies were used: Alexa-568-conjugated anti-276 
Rabbit (A-11011, ThermoFisher), anti-Goat (A11057, ThermoFisher), anti-Mouse (A-11004, 277 
ThermoFisher). Cells were then counterstained with phalloidin (A12379, ThermoFisher) and DAPI, 278 
and mounted with ProLong Diamond Antifade mounting medium (P36965, ThermoFisher). 279 
Staining was imaged with a Leica SP8 Confocal Scanning Laser Microscope. 280 
Quantification of axonal growth 281 
Axonal growth was quantified using AxoFluidic (developed by Estrela Neto [32]). 282 
AxoFluidic© uses the following function to model and quantify axonal growth: 283 
(𝑥)=𝐴 𝑥exp(− 𝑥λ), with: A: degree of axons that effectively cross the grooves; X: spatial 284 
variable; λ: scale of spatial decay  length of neurites. 285 
Analysis was performed on n = 4 microfluidic co-cultures per condition, and A and values 286 
plotted and analyzed with GraphPad Prism 8.0©. 287 
 288 
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RESULTS  290 
Human dental pulp stem cells and human bone marrow stromal cells express neurotrophins 291 
We first investigated whether hDPSCs and hBMSCs express neurotrophins (NTFs), key 292 
promoters of axonal outgrowth. We thus analyzed by real time PCR the expression of the genes 293 
coding for nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), glial-derived 294 
neurotrophic factor (GDNF) and neurotrophin-3 (NT-3). Expression of all genes was detectable in 295 
both hDPSCs and hBMSC. We observed that, compared to hBMSCs, hDPSCs express higher levels 296 
of all these NTFs. The highest difference was observed in the expression of GDNF and NT-3, with 297 
hDPSCs expressing 5-10-fold higher levels of these genes (Fig. 1C, D). NGF expression was also 298 
higher in hDPSCs (Fig. 1A). In contrast, BDNF expression did not differ significantly between the 299 
two cell populations (Fig 1B).  300 
We verified the expression of NTFs at the protein level. Immunofluorescent staining showed 301 
expression of NGF, BDNF, GDNF and NT-3 both in hDPSCs (Figure 1E-H) and hBMSCs (Figure 302 
1I-L; Figure 1M: negative control). NGF, BDNF and GDNF were also secreted in the culture 303 
medium at low, but detectable levels (Figure 1N-P). These three neurotrophic factors were found in 304 
higher concentrations in the medium exposed to hDPSCs (Figure 1N-P).   305 
 306 
Co-culture of trigeminal or dorsal root ganglia and MSCs in microfluidic devices 307 
We then set out to investigate whether hDPSCs and hBMSCs exert different neurotrophic 308 
effects on trigeminal and dorsal root neurons.  309 
We first optimized the conditions for the culture of whole trigeminal ganglia, dorsal root 310 
ganglia, and hDPSCs or hBMSCs. Ganglia were isolated from E14.5-E16.5 C57/BL6J mouse 311 
embryos and cultured alone on the somal side for 4 days. Neurotrophin receptors TrkA, TrkB, TrkC 312 
and p75/NGFR could be detected in both trigeminal and dorsal root ganglia both at the mRNA and 313 
protein level, (Figure 2A-H; J-L). Similar to what is observed in vivo [33–35], trigeminal and dorsal 314 
root ganglia expressed the sensory neuron marker CGRP (Calcitonin Gene Related Peptide; Figure 315 
2I).  316 
We then compared the neurotrophic properties of hDPSCs and hBMSCs. For our study we 317 
exploited an Organs-on-Chips system composed of a PDMS (Polydimethylsiloxane) microfluidic 318 
device mounted on a poly-D-lysine- and laminin-coated glass coverslip (Figure 3A, 3E). The device 319 
is a two-chamber system, each composed of two wells and an interconnected channel, separated by 320 
a set of 150 m long, 5 m wide microgrooves. The hydrostatic pressure formed by the volume 321 
differential between chambers induces fluidic isolation of the solution on the low volume side of the 322 
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device. Medium exchange was additionally limited by changing the culture medium every 48 hours. 323 
This system allows the culture of neuronal cell bodies and mesenchymal stem cells in their own 324 
culture media. As trigeminal neurons cell bodies and mesenchymal stem cells have different culture 325 
media requirements [30], this set up is optimal for the correct emulation of physiological 326 
interactions between these cell types. For culture of whole trigeminal ganglia, a hole of 1mm of 327 
diameter was performed with a biopsy punch in the middle of a culture chamber 1 (Figure 3B, F).  328 
Axonal outgrowth is limited to narrow and parallel channels, and the resultant behavior can be 329 
easily imaged. This system is thus a powerful tool for the study of neurites and synaptic formation. 330 
We thus exploited this system to compare the neurotrophic properties of hDPSCs and hBMSCs. 331 
To this end, we analyzed neurite outgrowth of trigeminal ganglia co-cultured with hDPSCs and 332 
hBMSCs. Once trigeminal axonal outgrowth was detected on the axonal side, target cells were 333 
added to the microfluidic device (Figure 3A, B, E, F). Trigeminal ganglia and target cells were co-334 
cultured for 4 days, stained for the pan-neuronal marker neurofilament and then analyzed by wide-335 
field fluorescent microscopy (Figure 3C, D, G, H). We observed that trigeminal ganglia formed 336 
nerve-like structures, with large axon bundles forming both on the somal and the axonal side 337 
(Figure 3D). Most axons projecting from trigeminal ganglia and neurons cultured with hDPSCs 338 
reached the most distant end of the axonal chamber (Figure 3D). In contrast, most axons grown in 339 
presence of hBMSCs did not reach the opposite end of the axonal chamber within the culture period 340 
(Figure 3H). Axonal outgrowth was quantified using the Axofluidic software [32]. The analysis 341 
showed that trigeminal ganglia when co-cultured with hDPSCs grew significantly longer axons than 342 
when co-cultured with hBMSCs (Fig. 3I, -value). At the same time, no difference was detected in 343 
the fraction of axons that reached the axonal side upon culture with hDPSCs or hBMSCs (Fig. 3I, A 344 
constant). 345 
We next performed an analogous experiment by co-culturing hDPSCs or hBMSCs with dorsal 346 
root ganglia (DRG) (Figure 4A-F). DRG innervate non-cranial bones, and hBMSCs, in vivo [36], 347 
while they do not target hDPSCs. Similar to what observed for TGG, hDPSCs promoted the growth 348 
of longer axons (Figure 4G), while not influencing the proportion of axons that reach the axonal 349 
chamber (Figure 4H).     350 
 351 
Axonal branching and establishment of axon-cells contacts 352 
We further analyzed the pattern of axonal growth and the establishment of axon/target contacts 353 
in presence of hDPSCs or hBMSCs. Staining against the neuronal markers III-tubulin and 354 
neurofilament, and the MSCs marker vimentin showed that hDPSCs elicit the formation of complex 355 
axonal networks, which establish extensive and recurrent contacts with target cells (Fig. 5A, C). To 356 
 13 
investigate whether these contacts are associated with synapses, we performed immunostaining 357 
against Synapsin I, a neuronal phosphoprotein that coats synaptic vesicles and modulates 358 
neurotransmitter release. We observed that the dense axonal networks contacting hDPSCs were 359 
characterized by very evident accumulation of Synapsin I (Figure 5C, D).  360 
In contrast to what observed with hDPSC, axons innervating hBMSCs had a more linear 361 
course, with less abundant collateral branches and less extensive contacts with the target cells 362 
(Figure 5B, E). Accordingly, accumulation of Synapsin I was only detectable at the few sites of 363 




Continuous efforts are spent to identify easily accessible sources of MSCs that could be 368 
successfully applied in clinics, not only for their regenerative properties, but also for taking 369 
advantage of their modulatory effects on the surrounding tissues [1, 6, 37]. Although the final 370 
clinical success of tissue regeneration relies heavily on understanding the mode of action of MSCs, 371 
in many cases their clinical use has proceeded the necessary understanding of their physiology [37]. 372 
Only lately, attention has been drawn to the fact that MSCs isolated from different sources are not 373 
only developmentally different but also widely diverge in their transcriptomic signatures, 374 
differentiation potential and biological functions [37, 38]. Among these, the promotion of the 375 
innervation of the regenerated tissue is an often neglected but fundamental aspect. Correct 376 
innervation is necessary for the function of most organs, including bone [39, 40] and teeth [12, 19, 377 
41]. Innervation modulates bone development and remodeling [39, 42], and it is directly involved in 378 
tooth reparative processes [43, 44]. Craniofacial traumatic injuries, as well as surgical interventions, 379 
often lead to trigeminal nerve damage or resection, resulting not only in the loss of sensation but 380 
also in the impairment of homeostatic and regenerative processes that depend on nerve-derived 381 
signals [22, 24, 45, 46]. Any regenerative therapy should thus also integrate the innervation of the 382 
repaired tissue. Nerve fibers should not be only attracted towards their targets, i.e. the regenerating 383 
tissues, but they should also form long-lasting functional contacts and interactions. 384 
Our results clearly show that, compared to hBMSCs, hDPSCs elicit the growth of longer axons, 385 
both from trigeminal and dorsal root ganglia neurons. This is noteworthy given that hBMSCs are 386 
considered the golden standard for MSC-mediated bone regenerative processes [38, 41]. In 387 
addition, hDPSCs may induce the formation of more extensive axonal networks, thus suggesting 388 
that their use in clinics for reparative purposes will confer tissues with an abundant and rich 389 
innervation. This is supported by findings in other damaged organs, such as the spinal cord and 390 
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retina, showing that hDPSCs display greater neurotrophic capabilities than hBMSCs [47, 48]. This 391 
is in agreement with our results showing that hDPSCs induce the growth of longer axons when co-392 
cultured with dorsal root ganglia, whose axons innervate non-cranial bones and hBMSCs in vivo 393 
[36].  We and others showed that hDPSCs express and secrete higher levels of neurotrophins than 394 
hBMSCs (Figure 2) [48], which could explain the  superior neurotrophic effects of hDPSCs. 395 
Nevertheless, the varied effects of different MSCs populations on afferent nerves depend on more 396 
factors than the expression of neurotrophins [48]. Thus, hDPSCs might provide a plethora of 397 
molecular cues beyond the expression and secretion of neutrophins that cumulatively result in the 398 
observed higher axonal growth and extensive neuronal network. While numerous studies 399 
investigated the neurotrophic properties of hDPSCs and hBMSCs in clinically relevant contexts 400 
such as spinal cord injury [49, 50] and ischemia [51], surprisingly few studies focus on their effects 401 
on trigeminal innervation. It has been long known that the responses of specific neuronal 402 
populations to neurotrophic signals can significantly differ, partially due to the relative expression 403 
of different neurotrophin receptors [52].  404 
A pivotal challenge in craniofacial regeneration is the re-establishment of a correct and 405 
functional trigeminal innervation, and thus the identification of a MSC population that can ensure 406 
proper re-innervation specifically by trigeminal neurons is of paramount importance. Our study 407 
provides evidence that for the regeneration of craniofacial tissues, which are innervated by 408 
trigeminal nerves, hDPSCs represent a more suitable choice than hBMSCs. Sensory alterations and 409 
damages to trigeminal nerves are common in maxillofacial surgical procedures involving both 410 
tissue removal and regeneration, and constitute an important postoperative issue [24, 25, 46, 53, 411 
54]. There is therefore a pressing need for proper therapeutic alternatives to ectopic nerve 412 
engraftment, which is invasive and often suboptimal. As different studies have demonstrated the 413 
potential of hDPSCs to regenerate craniofacial bone in human patients [55, 56], our results show 414 
that these cells could also be the basis for the successful innervation of the regenerated tissue. 415 
Increasing evidence indicates that “organs-on-chips” systems represent faithful models of in 416 
vivo processes, and are now the method of choice for the emulation of complex in vivo processes in 417 
controlled and defined environments [28, 57]. Human cells and tissues grown in these culture 418 
devices can maintain higher levels of tissue-specific differentiated functions in vitro [58], and have 419 
been used to model also pathological human conditions [59]. Thanks to these properties, organs-on-420 
chips are increasingly being used for the identification of new drugs and the study of their 421 
pharmacokinetic and pharmacodynamic properties [58, 60]. As such, these systems could be 422 
exploited to study the effects of neurotrophins, synthetic neurotrophin analogues [61] and other 423 
therapeutic agents on the interactions between trigeminal neurons and their targets within the 424 
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craniofacial complex. Aside from the scientific advantages, the use of such systems for in vitro 425 
modelling is a key axis of the research aiming at the refinement, replacement and reduction (3R) of 426 
experimental animal use [62]. We already demonstrated that the co-culture system employed in this 427 
study can faithfully model the pattern of tooth innervation observed in vivo [30], strongly 428 
suggesting that the results observed in the current study are representative of in vivo conditions. 429 
 430 
CONCLUSIONS 431 
These results demonstrate that, compared to hBMSCs, hDPSCs induce more extensive axonal 432 
growth, the formation of a richer neuronal network, and allow establishment of connections 433 
between them and axons. This information is essential for the design of novel stem cell-based 434 
therapeutic approaches aimed at the appropriate re-innervation of damaged craniofacial tissues. 435 
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Figure Legends 618 
Figure 1. Expression of neurotrophins in hDPSCs and hBMSCs in vitro. A-D) Real time PCR 619 
analysis of the expression of genes coding for NGF, BDNF, GDNF, NT3 in hDPSCs and hBMSCs 620 
isolated from different patients. Results are expressed in fold change to the expression level of 621 
GAPDH. E-M) Immunofluorescent staining showing the expression of NGF, BDNF, GDNF and 622 
NT-3 proteins (red color) in hDPSCs (E-H, upper row) and hBMSCs (I, L lower row). M: negative 623 
control. N-P) ELISA analysis of neurotrophins’ secretion by cultured hDPSCs and hBMSCs. 624 
Abbreviations: NGF, nerve growth factor; BDNF, brain-derived neurotrophic factor; GDNF, glial-625 
derived neurotrophic factor; NT-3, neurotrophin 3; GAPDH:  Glyceraldehyde 3-phosphate 626 
dehydrogenase. Scale bars: 20 m. * = p < 0.05; ** = p < 0.01. 627 
 628 
Figure 2. Expression of neurotrophin receptors and neuronal-specific proteins in trigeminal 629 
and dorsal root ganglia. A) Bright-field image of a cultured trigeminal ganglion. B-D) Real time 630 
PCR analysis of the expression of genes coding for Ntrk1, Ntrk2, Ntrk3, NGFR in TGG and DRG. 631 
E-K) Immunofluorescent staining showing expression of TrkA, TrkB, TrkC, p75/NGFR, calcitonin 632 
gene related peptide (CGRP) and neurofilament in ganglia. L) Western blot confirming expression 633 
of TrkA, TrkB, TrkC and p75/NGFR in TGG. Scale bars: A, 2 mm; E-H: 500 m; I-K: 40 m. 634 
Figure 3. Comparison of axonal growth from trigeminal ganglia (TGGs) co-cultured with 635 
hDPSCs or hBMSCs. A) Experimental approach for TGGs and hDPSCs co-culture. B) Brightfield 636 
overview of TGG co-cultured with hDPSCs C) Immunofluorescent staining (neurofilament, green 637 
color) showing exemplary axonal growth in presence of hDPSCs. D) Immunofluorescent staining 638 
showing growth of TGG axons (neurofilament, green color) in the presence of hDPSCs (DAPI, blue 639 
color). Notice that many axons reach the terminal end of the microfluidic chamber. White dotted 640 
lines show the borders of the microfluidic chamber containing hDPSCs. E) Experimental approach 641 
for TGGs and hDPSCs co-culture. F) Bright-field overview of TGG co-cultured with hBMSCs. G) 642 
Immunofluorescent staining (neurofilament, green color) showing exemplary axonal growth in 643 
presence of hBMSCs. H) Immunofluorescent staining showing growth of TGG axons 644 
(neurofilament, green color) in the presence of hBMSCs (DAPI, blue color). Notice that no or few 645 
axons reach the terminal end of the microfluidic chamber. White dotted lines show the borders of 646 
the microfluidic chamber containing hBMSCs. I) Graphs depicting the parameter, indicative of 647 
axonal length, and the A parameter, representing the fraction of axons that reach the axonal side. 648 
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Abbreviations: hBMSCs, human bone marrow stem cells; hDPSCs, human dental pulp stem cells; 649 
mg, microgrooves; TGGs, trigeminal ganglia. Scale bars: B, F: 1 mm; D, H: 300 m. 650 
Figure 4. Comparison of axonal growth from dorsal root ganglia (DRG) co-cultured with 651 
hDPSCs or hBMSCs. A) Overview of axonal growth from DRG cultured in the presence of 652 
hDPSCs. B, C) Immunofluorescent staining showing contacts between axons (NF200, red color) 653 
and hDPSCs (vimentin, green color). D) Overview of axonal growth from DRG cultured in the 654 
presence of hBMSCs. E, F) Immunofluorescent staining showing contacts between axons (NF200, 655 
red color) and hBMSCs (vimentin, green color). G) Graph depicting the parameter, indicative of 656 
axonal length. H) Graph depicting the A parameter, representing the fraction of axons that reach the 657 
axonal side. Abbreviations: hBMSCs, human bone marrow stem cells; hDPSCs, human dental pulp 658 
stem cells; DRG, dorsal root ganglia. Scale bars: A, D: 300 m; B, C, E, F: 50 m. 659 
Figure 5. Trigeminal axons form extensive networks and contacts when cultured in the 660 
presence of hDPSCs. A, B) Immunofluorescent staining showing trigeminal axons networks (III-661 
tubulin, green color) innervating hDPSCs (A) and hBMSCs (B) (III-tubulin, green color; DAPI, 662 
blue color). C) Immunofluorescent staining showing extensive contacts established by trigeminal 663 
axons (neurofilament, green color) with hDPSCs (vimentin, red color). D) Immunofluorescent 664 
staining showing strong accumulation of Synapsin (red color) at the contact sites between 665 
trigeminal axons (neurofilament, green color) and hDPSCs (white dotted line: cell borders). E) 666 
Immunofluorescent staining showing growth of trigeminal axons (neurofilament, green color) 667 
mostly along and past hBMSCs (vimentin, red color). F) Immunofluorescent staining showing few 668 
contacts (Synapsin accumulation, red color) established by trigeminal axons (neurofilament, green 669 
color) with hBMSCs. White arrowheads: points of contact between trigeminal neurons and hDPSCs 670 
or hDPSCs. Abbreviations: hBMSCs, human bone marrow stem cells; hDPSCs, human dental pulp 671 
stem cells; TGG, trigeminal ganglion. Scale bars: A, B: 25 m; C-F: 20 m. 672 
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